Today's special offer: Access for Free!!!

Merck & Co. Inc. (MRK) | Analysis of Inventory

Inventory Accounting Policy

Inventories are valued at the lower of cost or market. The cost of a substantial majority of domestic pharmaceutical and vaccine inventories is determined using the last-in, first-out ("LIFO") method for both financial reporting and tax purposes. The cost of all other inventories is determined using the first-in, first-out ("FIFO") method. Inventories consist of currently marketed products and certain products awaiting regulatory approval. In evaluating the recoverability of inventories produced in preparation for product launches, Merck considers the probability that revenue will be obtained from the future sale of the related inventory together with the status of the product within the regulatory approval process.

Source: Merck & Co. Inc., Annual Report

Inventory Disclosure

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Merck & Co. Inc., Statement of Financial Position, Inventory

USD $ in millions

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Finished goods
chart Raw materials and work in process
chart Supplies
chart Inventories, approximates current cost
chart Reduction to LIFO costs
chart Inventories
chart Less: Inventories recognized as other assets
chart Inventories (excludes inventories classified in other assets)

Source: Based on data from Merck & Co. Inc. Annual Reports

Item Description The company
Finished goods Carrying amount as of the balance sheet date of merchandise or goods held by the company that are readily available for sale. Merck & Co. Inc.'s finished goods declined from 2009 to 2010 but then increased from 2010 to 2011 not reaching 2009 level.
Raw materials and work in process The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. Includes supplies used directly or indirectly in the manufacturing or production process. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount. Merck & Co. Inc.'s raw materials and work in process declined from 2009 to 2010 and from 2010 to 2011.
Supplies Carrying amount as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods. Merck & Co. Inc.'s supplies declined from 2009 to 2010 and from 2010 to 2011.
Inventories (excludes inventories classified in other assets) Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer). Merck & Co. Inc.'s inventories (excludes inventories classified in other assets) declined from 2009 to 2010 but then slightly increased from 2010 to 2011.

Adjustment to Inventory: from LIFO to FIFO

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Adjusting LIFO Inventory to FIFO (Current) Cost

USD $ in millions

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  Adjustment to Inventories (excludes Inventories Classified In Other Assets)
chart Inventories (excludes inventories classified in other assets) at LIFO (as reported)
chart Add: LIFO reserve, ending balance
chart Inventories (excludes inventories classified in other assets) at FIFO (adjusted)
  Adjustment to Current Assets
chart Current assets (as reported)
chart Add: LIFO reserve, ending balance
chart Current assets (adjusted)
  Adjustment to Total Assets
chart Total assets (as reported)
chart Add: LIFO reserve, ending balance
chart Total assets (adjusted)
  Adjustment to Merck & Co., Inc. Stockholders’ Equity
chart Merck & Co., Inc. stockholders’ equity (as reported)
chart Add: LIFO reserve, ending balance
chart Merck & Co., Inc. stockholders’ equity (adjusted)
  Adjustment to Net Income Attributable To Merck & Co., Inc.
chart Net income attributable to Merck & Co., Inc. (as reported)
chart Add: Increase (decrease) in LIFO reserve, ending balance
chart Net income attributable to Merck & Co., Inc. (adjusted)

Merck & Co. Inc.'s inventory value on Dec 31, 2011 would be $6,297  (in millions) if the FIFO inventory method was used instead of LIFO. Merck & Co. Inc.'s inventories, valued on a LIFO basis, on Dec 31, 2011 were $6,254 . Merck & Co. Inc.'s inventories would have been $43  higher than reported on Dec 31, 2011 if the FIFO method had been used instead.

Adjusted Ratios: LIFO vs. FIFO (Summary)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Merck & Co. Inc., adjusted ratios

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  Current Ratio
chart Reported current ratio (LIFO)
chart Adjusted current ratio (FIFO)
  Net Profit Margin
chart Reported net profit margin (LIFO) % % % % %
chart Adjusted net profit margin (FIFO) % % % % %
  Total Asset Turnover
chart Reported total asset turnover (LIFO)
chart Adjusted total asset turnover (FIFO)
  Financial Leverage
chart Reported financial leverage (LIFO)
chart Adjusted financial leverage (FIFO)
  Return on Equity (ROE)
chart Reported ROE (LIFO) % % % % %
chart Adjusted ROE (FIFO) % % % % %
  Return on Assets (ROA)
chart Reported ROA (LIFO) % % % % %
chart Adjusted ROA (FIFO) % % % % %
Ratio Description The company
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by current liabilities. Merck & Co. Inc.'s adjusted current ratio improved from 2009 to 2010 and from 2010 to 2011.
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Merck & Co. Inc.'s adjusted net profit margin deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Merck & Co. Inc.'s adjusted total asset turnover improved from 2009 to 2010 and from 2010 to 2011.
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.
Merck & Co. Inc.'s adjusted financial leverage increased from 2009 to 2010 but then slightly declined from 2010 to 2011.
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted shareholders' equity. Merck & Co. Inc.'s adjusted ROE deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Merck & Co. Inc.'s adjusted ROA deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.

Adjusted Current Ratio

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Current assets (USD $ in millions)
chart Current liabilities (USD $ in millions)
   
chart Current ratio1
  Adjusted: from LIFO to FIFO
chart Adjusted current assets (USD $ in millions)
chart Current liabilities (USD $ in millions)
   
chart Adjusted current ratio2

2011 Calculations

1 Current ratio = Current assets ÷ Current liabilities
= ÷ =

2 Adjusted current ratio = Adjusted current assets ÷ Current liabilities
= ÷ =

Ratio Description The company
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by current liabilities. Merck & Co. Inc.'s adjusted current ratio improved from 2009 to 2010 and from 2010 to 2011.

Adjusted Net Profit Margin

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Sales (USD $ in millions)
   
chart Net profit margin1 % % % % %
  Adjusted: from LIFO to FIFO
chart Adjusted net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Sales (USD $ in millions)
   
chart Adjusted net profit margin2 % % % % %

2011 Calculations

1 Net profit margin = 100 × Net income attributable to Merck & Co., Inc. ÷ Sales
= 100 × ÷ = %

2 Adjusted net profit margin = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Sales
= 100 × ÷ = %

Ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by revenue. Merck & Co. Inc.'s adjusted net profit margin deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.

Adjusted Total Asset Turnover

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Sales (USD $ in millions)
chart Total assets (USD $ in millions)
   
chart Total asset turnover1
  Adjusted: from LIFO to FIFO
chart Sales (USD $ in millions)
chart Adjusted total assets (USD $ in millions)
   
chart Adjusted total asset turnover2

2011 Calculations

1 Total asset turnover = Sales ÷ Total assets
= ÷ =

2 Adjusted total asset turnover = Sales ÷ Adjusted total assets
= ÷ =

Ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Merck & Co. Inc.'s adjusted total asset turnover improved from 2009 to 2010 and from 2010 to 2011.

Adjusted Financial Leverage

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Total assets (USD $ in millions)
chart Merck & Co., Inc. stockholders’ equity (USD $ in millions)
   
chart Financial leverage1
  Adjusted: from LIFO to FIFO
chart Adjusted total assets (USD $ in millions)
chart Adjusted merck & Co., Inc. stockholders’ equity (USD $ in millions)
   
chart Adjusted financial leverage2

2011 Calculations

1 Financial leverage = Total assets ÷ Merck & Co., Inc. stockholders’ equity
= ÷ =

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted merck & Co., Inc. stockholders’ equity
= ÷ =

Ratio Description The company
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.
Merck & Co. Inc.'s adjusted financial leverage increased from 2009 to 2010 but then slightly declined from 2010 to 2011.

Adjusted Return On Equity (ROE)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Merck & Co., Inc. stockholders’ equity (USD $ in millions)
   
chart ROE1 % % % % %
  Adjusted: from LIFO to FIFO
chart Adjusted net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Adjusted merck & Co., Inc. stockholders’ equity (USD $ in millions)
   
chart Adjusted ROE2 % % % % %

2011 Calculations

1 ROE = 100 × Net income attributable to Merck & Co., Inc. ÷ Merck & Co., Inc. stockholders’ equity
= 100 × ÷ = %

2 Adjusted ROE = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Adjusted merck & Co., Inc. stockholders’ equity
= 100 × ÷ = %

Ratio Description The company
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted shareholders' equity. Merck & Co. Inc.'s adjusted ROE deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.

Adjusted Return On Assets (ROA)

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Export to Excel Export to OpenOffice.org
    Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
  As Reported
chart Net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Total assets (USD $ in millions)
   
chart ROA1 % % % % %
  Adjusted: from LIFO to FIFO
chart Adjusted net income attributable to Merck & Co., Inc. (USD $ in millions)
chart Adjusted total assets (USD $ in millions)
   
chart Adjusted ROA2 % % % % %

2011 Calculations

1 ROA = 100 × Net income attributable to Merck & Co., Inc. ÷ Total assets
= 100 × ÷ = %

2 Adjusted ROA = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Adjusted total assets
= 100 × ÷ = %

Ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Merck & Co. Inc.'s adjusted ROA deteriorated from 2009 to 2010 but then slightly improved from 2010 to 2011.

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center